QA: Larimar Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001374690_2019_Larimar_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001374690, Larimar Therapeutics Inc

  xvar xval
0 AssetsCurrent 121,330,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 375,000
3 remainder_Assets 57,000
4 LiabilitiesCurrent 13,306,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 15,185,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,148,840
9 ResearchAndDevelopmentExpense 46,496,975
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 168,550
13 remainder_ComprehensiveNetIncome 23,704
  yvar yval
0 Assets 121,762,000
1 Liabilities 28,491,000
2 Expenses 59,645,815
3 Revenues 0
4 StockholdersEquity 93,271,000
5 NetIncome -59,477,265
6 ComprehensiveNetIncome -59,465,413
7 BaseVar 105,045,534
8 EconomicCapitalRatiobeforeLimitedLiability 1.91
9 EconomicCapitalRatio 2.97

Edgar->Model Mapping

Feature Distribution

Change over Time